Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Build fair machine learning models to predict adverse outcomes for heart failure patients with preserved ejection fraction and with reduced ejection fraction.

JAMIA open·2026
Same author

Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.

Biochemical pharmacology·2026
Same author

Innovative Insights into Interleukin-Mediated Macrophage Polarization: Metabolic Reprogramming and Inflammatory Pathway Crosstalk in Chronic Kidney Disease and Therapeutic Implications-A Narrative Review.

International journal of general medicine·2026
Same author

EGCG inactivates tumor necrosis factor-alpha (TNFα) by inducing its higher-order assembly.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Ligustilide activates cGAS-STING to chemoprevent tobacco carcinogen-induced lung tumorigenesis.

International immunopharmacology·2026
Same author

IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Blood·2026

Related Experiment Video

Updated: May 22, 2025

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

1.5K

Recent Advances in Pineoblastoma Research: Molecular Classification, Modelling and Targetable Vulnerabilities.

Zhe Jiang1, Michelle S Allkanjari1, Philip E D Chung1

  • 1Toronto General Research Institute, University Health Network, 101 College Street, Max Bell Research Centre, Suite 5R406, Toronto, ON M5G 1L7, Canada.

Cancers
|March 13, 2025
PubMed
Summary

Pineoblastoma (PB) is a rare pediatric brain cancer. Understanding its subtypes and developing new models offers hope for targeted therapies and improved outcomes for children with this lethal disease.

Keywords:
Dicer1DroshaMYCRB1brain cancerclassificationmetastasismouse modelspineoblastomaprecision medicine

More Related Videos

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
09:24

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

9.0K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

16.8K

Related Experiment Videos

Last Updated: May 22, 2025

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

1.5K
Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
09:24

Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing

Published on: June 9, 2016

9.0K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

16.8K

Area of Science:

  • Pediatric neuro-oncology
  • Cancer genomics
  • Epigenetics

Background:

  • Pineoblastoma (PB) is a rare, lethal pediatric brain cancer originating in the pineal gland.
  • Current treatments offer limited survival rates, especially for metastatic disease, and cause significant neurocognitive deficits.
  • PB comprises distinct molecular subtypes with varying prognoses, including those driven by DICER/DROSHA, RB1, and cMYC.

Purpose of the Study:

  • To advance the understanding of pineoblastoma heterogeneity and progression.
  • To highlight the importance of preclinical models for therapeutic development.
  • To identify potential vulnerabilities for novel treatment strategies.

Main Methods:

  • Review of recent advancements in pineoblastoma research, including molecular subtyping.
  • Discussion of established and emerging preclinical models for PB subtypes.
  • Analysis of disease mechanisms, cell of origin, and therapeutic targets.

Main Results:

  • Pineoblastoma is classified into major subtypes based on genetic drivers (DICER/DROSHA loss, RB1 loss, cMYC amplification).
  • Mouse models have been successfully developed for RB1-, DICER1-, and DROSHA-driven PB, but not yet for MYC-driven PB.
  • Progress has been made in understanding PB biology, including tumor progression and the role of autophagy.

Conclusions:

  • Subtyping and preclinical models are crucial for developing precision therapies for pineoblastoma.
  • Further research into MYC-driven PB and targetable vulnerabilities is needed.
  • Improved understanding holds promise for novel therapeutic strategies against this childhood malignancy.